Immunotherapy with autologous tumor lysates-pulsed dentritic cells for patients with metastatic renal cell carcinoma

被引：0
|
作者：
Kim, Jung Han
Jung, Chul Won
Park, Jinny
Kim, Ho Young
Kim, Kihyun
Kim, Won Seog
Park, Young Suk
Im, Young-Hyuck
Kang, Won Ki
Park, Keunchil
机构：
[1] Hallym Univ, Kang Nam Sacred Heart Hosp, Coll Med, Dept Internal Med,Div Hematooncol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[3] Jeju Natl Univ, Jeju Natl Univ Hosp, Coll Med, Dept Internal Med,Div Hematooncol, Cheju, South Korea
[4] Wonju Univ, Sch Med, Dept Med, Div Hematol Oncol, Wonju, South Korea
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：153 / 153
页数：1
相关论文
共 50 条
  • [31] IMMUNOTHERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    BELLDEGRUN, A
    FIGLIN, R
    HAAS, G
    DEKERNION, J
    WORLD JOURNAL OF UROLOGY, 1991, 9 (03) : 157 - 159
  • [32] IMMUNOTHERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    WIRTH, MP
    UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (02) : 283 - 295
  • [33] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15
  • [34] The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ
    Bex, A
    Horenblas, S
    Meinhardt, W
    Verra, N
    de Gast, GC
    EUROPEAN UROLOGY, 2002, 42 (06) : 570 - 574
  • [35] G250-peptide-pulsed dendritic cells in patients with metastatic renal cell carcinoma
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 232 - 232
  • [36] Comment on: "Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy"
    Sener, Yusuf Ziya
    Begijanashvili, Salome
    TARGETED ONCOLOGY, 2022, 17 (04) : 493 - 494
  • [37] Evidence of pseudoprogression in metastatic renal cell carcinoma patients treated with immunotherapy
    Jain, Rohit
    Azabdaftari, Gissou
    Sikorski, Marcus
    Herbst, Laurie
    George, Saby
    BJU INTERNATIONAL, 2016, 118 : 21 - 22
  • [38] Comment on: “Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy”
    Yusuf Ziya Şener
    Salome Begijanashvili
    Targeted Oncology, 2022, 17 : 493 - 494
  • [39] PROGNOSTIC FACTORS OF METASTATIC RENAL CELL CARCINOMA PATIENTS IN THE IMMUNOTHERAPY ERA
    La Russa, F.
    Riolfi, M.
    Sava, T.
    Ghimenton, C.
    Porcaro, A.
    Cesaro, G.
    Consoli, F.
    Manno, P.
    Pavarana, M.
    Cetto, G. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 197 - 197
  • [40] Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
    Zhang, Yajing
    Wang, Jin
    Wang, Yao
    Lu, Xue-Chun
    Fan, Hui
    Liu, Yang
    Zhang, Yan
    Feng, Kai-Chao
    Zhang, Wen-Ying
    Chen, Mei-Xia
    Fu, Xiaobing
    Han, Wei-Dong
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
12345